The extracellular matrix (ECM) of the brain is a dynamic structure made up of a vast network
of bioactive macromolecules that modulate cellular events. Structural, organizational, and …

Molecular mechanisms of Parkinson's disease (PD) have already been investigated in
various different omics landscapes. We reviewed the literature about different omics …

Parkinson disease (PD) is the second most progressive neurodegenerative disorder of the
central nervous system (CNS) in the elderly, causing motor impediments and cognitive …

Disruption of the gut‐brain axis in Parkinson's disease (PD) may lead to motor symptoms
and PD pathogenesis. Recently, the neuroprotective potential of different PPARδ‐agonists …

Parkinson's disease (PD) is an age-related, threatening neurodegenerative disorder with no
reliable treatment till date. Identification of specific and reliable biomarker is a major …

Parkinson's disease (PD) is a chronic and progressive age-related neurodegenerative
disease affecting up to 3% of the global population over 65 years of age. Currently, the …

Parkinson's disease (PD) is characterized by complex motor and non-motor symptoms that
vary in onset, severity, response to treatment, and disability. The unpredictable and …

Parkinson's disease (PD) is a chronic and progressive movement disorder that is
characterized by the loss of dopaminergic neurons in the brain. Animal models of PD have …

Given that global prevalence of Parkinson's disease (PD) is expected to rise over the next
few decades, understanding the mechanisms and causes of PD is critical. With emphasis on …

Neurodegenerative diseases present complex genetic architectures, reflecting a continuum
from monogenic to oligogenic and polygenic models. Recent advances in multi-omics data …